Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia
The COVID-19 (COronaVIrus Disease 2019) pandemic caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus 2) continues to be a global threat to people and health systems. As of March 21, 2022, there are more than 460 million cases and more than 6 million deaths worldwide, and more than 17...
Main Authors: | M. V. Ezhov, T. E. Kolmakova, M. M. Matveeva, I. A. Alekseeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2022-04-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6772 |
Similar Items
-
ATORVASTATIN IN ACUTE AND CHRONIC KINDS OF ISCHEMIC HEART DISEASE
by: V. E. Oleynikov, et al.
Published: (2015-11-01) -
Potential Benefits and Risks Associated with the Use of Statins
by: Nisha Khatiwada, et al.
Published: (2024-02-01) -
Effectiveness of statin treatment in reducing red cell distribution width and mean platelet volume in patients with stable coronary artery disease: A retrospective study
by: Ayse Colak, et al.
Published: (2022-01-01) -
HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
by: A. О. Shevchenko
Published: (2016-06-01) -
Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon?
by: I. A. Latfullin, et al.
Published: (2015-12-01)